ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Changes SBIR/STTG Application Receipt Dates.

February 18, 2000

Harvest Yet To Come From Radiotherapy Advances, Kaplan Tells NCAB

October 17, 1975

NCCN Publishes Anemia Guidelines

April 12, 2002

In Brief: Kristian Storm Names Chief Of Surgical Oncology At Univ. Of Wisconsin; Skibba To Join CTEP

November 13, 1987

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

June 24, 2011